EASD Archives -

Two diabetes drugs, Lilly and Boehringer Ingelheim’s (BI) Jardiance and Novo Nordisk’s Victoza, have shown they can go

The ‘game changers’ in diabetes: Novo and Lilly battle it out

https://pharmaphorum.com/views-and-analysis/diabetes-drugs-prevent-heart-attacks-strokes-novo-lilly-battle/

First company to put GLP-1 together with SGLT2 class

AZ success with novel diabetes combo

https://pharmaphorum.com/news/az-success-novel-diabetes-combo/

New data presented at EASD in Munich

Sanofi and Novo battle it out with diabetes combinations

https://pharmaphorum.com/news/sanofi-novo-battle-diabetes-combinations/

EASD